U.S. High Court Won't Hear Arguments That Punitives Are Preempted In Drug Cases

U.S. High Court Won't Hear Arguments That Punitives Are Preempted In Drug Cases

WASHINGTON, D.C. - The U.S. Supreme Court on Oct. 7 refused to hear arguments by Novartis Pharmaceuticals Corp. that federal drug regulations and high court precedent preempt the awarding of state law punitive damages in an Aredia/Zometa jaw injury case (Novartis Pharmaceuticals Corporation v. Herbert Fussman, et al., No. 12-1339, U.S. Sup.).

Find full version on lexis Advance®
Access this news story on lexis.com®